APO Research
Talk to an analyst

APO RESEARCH · REPORT

Emergency Hemostatic Agent

Compare research editions
View pricing & licenses

Selected research

Industry Research

Emergency Hemostatic Agent Industry Research Report 2026

19 December 2025133 pages

Choose your research edition.

Industry ResearchEmergency Hemostatic Agent Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Emergency Hemostatic Agent Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Emergency Hemostatic Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Emergency Hemostatic Agent Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Emergency Hemostatic Agent Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Emergency Hemostatic Agent market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Emergency Hemostatic Agent is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Emergency Hemostatic Agent is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Emergency Hemostatic Agent is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Emergency Hemostatic Agent include Advanced Medical Solutions, Anika Therapeutics, B Braun Melsungen, Baxter International, BioCer Entwicklungs, Biom’Up SAS, C. R. Bard, CryoLife and Equimedical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Emergency Hemostatic Agent market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Emergency Hemostatic Agent Market by Company

Advanced Medical Solutions

Anika Therapeutics

B Braun Melsungen

Baxter International

BioCer Entwicklungs

Biom’Up SAS

C. R. Bard

CryoLife

Equimedical

Ethicon

Gelita Medical

Integra LifeSciences

Marine Polymer Technologies

The Medicines Company

Vascular Solutions

Z-Medica

Pfizer

Emergency Hemostatic Agent Segment by Type

Gelation Sponge

Oxidized Regenerated Cellulose Based Hemostats

Others

Emergency Hemostatic Agent Segment by Application

Clnics

Hospitals

Surgical Centers

Others

Emergency Hemostatic Agent Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Emergency Hemostatic Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Emergency Hemostatic Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Emergency Hemostatic Agent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Emergency Hemostatic Agent manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Emergency Hemostatic Agent by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Emergency Hemostatic Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Emergency Hemostatic Agent Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Emergency Hemostatic Agent Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Emergency Hemostatic Agent Sales Market Share by Manufacturers (2021-2026) Table 8. Global Emergency Hemostatic Agent Revenue of Manufacturers (2021-2026) Table 9. Global Emergency Hemostatic Agent Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Emergency Hemostatic Agent Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Emergency Hemostatic Agent Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Emergency Hemostatic Agent, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Emergency Hemostatic Agent, Product Type & Application Table 14. Global Emergency Hemostatic Agent Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Emergency Hemostatic Agent by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Advanced Medical Solutions Company Information Table 19. Advanced Medical Solutions Business Overview Table 20. Advanced Medical Solutions Emergency Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Advanced Medical Solutions Emergency Hemostatic Agent Product Portfolio Table 22. Advanced Medical Solutions Recent Developments Table 23. Anika Therapeutics Company Information Table 24. Anika Therapeutics Business Overview Table 25. Anika Therapeutics Emergency Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Anika Therapeutics Emergency Hemostatic Agent Product Portfolio Table 27. Anika Therapeutics Recent Developments Table 28. B Braun Melsungen Company Information Table 29. B Braun Melsungen Business Overview Table 30. B Braun Melsungen Emergency Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. B Braun Melsungen Emergency Hemostatic Agent Product Portfolio Table 32. B Braun Melsungen Recent Developments Table 33. Baxter International Company Information Table 34. Baxter International Business Overview Table 35. Baxter International Emergency Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Baxter International Emergency Hemostatic Agent Product Portfolio Table 37. Baxter International Recent Developments Table 38. BioCer Entwicklungs Company Information Table 39. BioCer Entwicklungs Business Overview Table 40. BioCer Entwicklungs Emergency Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. BioCer Entwicklungs Emergency Hemostatic Agent Product Portfolio Table 42. BioCer Entwicklungs Recent Developments Table 43. Biom’Up SAS Company Information Table 44. Biom’Up SAS Business Overview Table 45. Biom’Up SAS Emergency Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Biom’Up SAS Emergency Hemostatic Agent Product Portfolio Table 47. Biom’Up SAS Recent Developments Table 48. C. R. Bard Company Information Table 49. C. R. Bard Business Overview Table 50. C. R. Bard Emergency Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. C. R. Bard Emergency Hemostatic Agent Product Portfolio Table 52. C. R. Bard Recent Developments Table 53. CryoLife Company Information Table 54. CryoLife Business Overview Table 55. CryoLife Emergency Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. CryoLife Emergency Hemostatic Agent Product Portfolio Table 57. CryoLife Recent Developments Table 58. Equimedical Company Information Table 59. Equimedical Business Overview Table 60. Equimedical Emergency Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Equimedical Emergency Hemostatic Agent Product Portfolio Table 62. Equimedical Recent Developments Table 63. Ethicon Company Information Table 64. Ethicon Business Overview Table 65. Ethicon Emergency Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Ethicon Emergency Hemostatic Agent Product Portfolio Table 67. Ethicon Recent Developments Table 68. Gelita Medical Company Information Table 69. Gelita Medical Business Overview Table 70. Gelita Medical Emergency Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Gelita Medical Emergency Hemostatic Agent Product Portfolio Table 72. Gelita Medical Recent Developments Table 73. Integra LifeSciences Company Information Table 74. Integra LifeSciences Business Overview Table 75. Integra LifeSciences Emergency Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Integra LifeSciences Emergency Hemostatic Agent Product Portfolio Table 77. Integra LifeSciences Recent Developments Table 78. Marine Polymer Technologies Company Information Table 79. Marine Polymer Technologies Business Overview Table 80. Marine Polymer Technologies Emergency Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Marine Polymer Technologies Emergency Hemostatic Agent Product Portfolio Table 82. Marine Polymer Technologies Recent Developments Table 83. The Medicines Company Company Information Table 84. The Medicines Company Business Overview Table 85. The Medicines Company Emergency Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. The Medicines Company Emergency Hemostatic Agent Product Portfolio Table 87. The Medicines Company Recent Developments Table 88. Vascular Solutions Company Information Table 89. Vascular Solutions Business Overview Table 90. Vascular Solutions Emergency Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Vascular Solutions Emergency Hemostatic Agent Product Portfolio Table 92. Vascular Solutions Recent Developments Table 93. Z-Medica Company Information Table 94. Z-Medica Business Overview Table 95. Z-Medica Emergency Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Z-Medica Emergency Hemostatic Agent Product Portfolio Table 97. Z-Medica Recent Developments Table 98. Pfizer Company Information Table 99. Pfizer Business Overview Table 100. Pfizer Emergency Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Pfizer Emergency Hemostatic Agent Product Portfolio Table 102. Pfizer Recent Developments Table 103. Global Emergency Hemostatic Agent Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 104. Global Emergency Hemostatic Agent Sales by Region (2021-2026) & (K Units) Table 105. Global Emergency Hemostatic Agent Sales Market Share by Region (2021-2026) Table 106. Global Emergency Hemostatic Agent Sales by Region (2027-2032) & (K Units) Table 107. Global Emergency Hemostatic Agent Sales Market Share by Region (2027-2032) Table 108. Global Emergency Hemostatic Agent Revenue by Region (2021-2026) & (US$ Million) Table 109. Global Emergency Hemostatic Agent Revenue Market Share by Region (2021-2026) Table 110. Global Emergency Hemostatic Agent Revenue by Region (2027-2032) & (US$ Million) Table 111. Global Emergency Hemostatic Agent Revenue Market Share by Region (2027-2032) Table 112. North America Emergency Hemostatic Agent Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. North America Emergency Hemostatic Agent Sales by Country (2021-2026) & (K Units) Table 114. North America Emergency Hemostatic Agent Sales by Country (2027-2032) & (K Units) Table 115. North America Emergency Hemostatic Agent Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Emergency Hemostatic Agent Revenue by Country (2027-2032) & (US$ Million) Table 117. Europe Emergency Hemostatic Agent Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Europe Emergency Hemostatic Agent Sales by Country (2021-2026) & (K Units) Table 119. Europe Emergency Hemostatic Agent Sales by Country (2027-2032) & (K Units) Table 120. Europe Emergency Hemostatic Agent Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Emergency Hemostatic Agent Revenue by Country (2027-2032) & (US$ Million) Table 122. Asia Pacific Emergency Hemostatic Agent Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Asia Pacific Emergency Hemostatic Agent Sales by Country (2021-2026) & (K Units) Table 124. Asia Pacific Emergency Hemostatic Agent Sales by Country (2027-2032) & (K Units) Table 125. Asia Pacific Emergency Hemostatic Agent Revenue by Country (2021-2026) & (US$ Million) Table 126. Asia Pacific Emergency Hemostatic Agent Revenue by Country (2027-2032) & (US$ Million) Table 127. South America Emergency Hemostatic Agent Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. South America Emergency Hemostatic Agent Sales by Country (2021-2026) & (K Units) Table 129. South America Emergency Hemostatic Agent Sales by Country (2027-2032) & (K Units) Table 130. South America Emergency Hemostatic Agent Revenue by Country (2021-2026) & (US$ Million) Table 131. South America Emergency Hemostatic Agent Revenue by Country (2027-2032) & (US$ Million) Table 132. Middle East and Africa Emergency Hemostatic Agent Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Middle East and Africa Emergency Hemostatic Agent Sales by Country (2021-2026) & (K Units) Table 134. Middle East and Africa Emergency Hemostatic Agent Sales by Country (2027-2032) & (K Units) Table 135. Middle East and Africa Emergency Hemostatic Agent Revenue by Country (2021-2026) & (US$ Million) Table 136. Middle East and Africa Emergency Hemostatic Agent Revenue by Country (2027-2032) & (US$ Million) Table 137. Global Emergency Hemostatic Agent Sales by Type (2021-2026) & (K Units) Table 138. Global Emergency Hemostatic Agent Sales by Type (2027-2032) & (K Units) Table 139. Global Emergency Hemostatic Agent Sales Market Share by Type (2021-2026) Table 140. Global Emergency Hemostatic Agent Sales Market Share by Type (2027-2032) Table 141. Global Emergency Hemostatic Agent Revenue by Type (2021-2026) & (US$ Million) Table 142. Global Emergency Hemostatic Agent Revenue by Type (2027-2032) & (US$ Million) Table 143. Global Emergency Hemostatic Agent Revenue Market Share by Type (2021-2026) Table 144. Global Emergency Hemostatic Agent Revenue Market Share by Type (2027-2032) Table 145. Global Emergency Hemostatic Agent Price by Type (2021-2026) & (US$/Unit) Table 146. Global Emergency Hemostatic Agent Price by Type (2027-2032) & (US$/Unit) Table 147. Global Emergency Hemostatic Agent Sales by Application (2021-2026) & (K Units) Table 148. Global Emergency Hemostatic Agent Sales by Application (2027-2032) & (K Units) Table 149. Global Emergency Hemostatic Agent Sales Market Share by Application (2021-2026) Table 150. Global Emergency Hemostatic Agent Sales Market Share by Application (2027-2032) Table 151. Global Emergency Hemostatic Agent Revenue by Application (2021-2026) & (US$ Million) Table 152. Global Emergency Hemostatic Agent Revenue by Application (2027-2032) & (US$ Million) Table 153. Global Emergency Hemostatic Agent Revenue Market Share by Application (2021-2026) Table 154. Global Emergency Hemostatic Agent Revenue Market Share by Application (2027-2032) Table 155. Global Emergency Hemostatic Agent Price by Application (2021-2026) & (US$/Unit) Table 156. Global Emergency Hemostatic Agent Price by Application (2027-2032) & (US$/Unit) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Emergency Hemostatic Agent Distributors List Table 160. Emergency Hemostatic Agent Customers List Table 161. Emergency Hemostatic Agent Industry Trends Table 162. Emergency Hemostatic Agent Industry Drivers Table 163. Emergency Hemostatic Agent Industry Restraints Table 164. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Emergency Hemostatic Agent Product Image Figure 5. Global Emergency Hemostatic Agent Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Emergency Hemostatic Agent Market Size (2021-2032) & (US$ Million) Figure 7. Global Emergency Hemostatic Agent Sales (2021-2032) & (K Units) Figure 8. Global Emergency Hemostatic Agent Average Price (US$/Unit) & (2021-2032) Figure 9. Gelation Sponge Product Image Figure 10. Oxidized Regenerated Cellulose Based Hemostats Product Image Figure 11. Others Product Image Figure 12. Clnics Product Image Figure 13. Hospitals Product Image Figure 14. Surgical Centers Product Image Figure 15. Others Product Image Figure 16. Global Emergency Hemostatic Agent Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Emergency Hemostatic Agent, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Emergency Hemostatic Agent Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Emergency Hemostatic Agent Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Emergency Hemostatic Agent Sales by Region in 2025 Figure 22. Global Emergency Hemostatic Agent Revenue by Region in 2025 Figure 23. North America Emergency Hemostatic Agent Market Size by Country in 2025 Figure 24. North America Emergency Hemostatic Agent Sales Market Share by Country (2021-2032) Figure 25. North America Emergency Hemostatic Agent Revenue Market Share by Country (2021-2032) Figure 26. United States Emergency Hemostatic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Emergency Hemostatic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Emergency Hemostatic Agent Market Size by Country in 2025 Figure 29. Europe Emergency Hemostatic Agent Sales Market Share by Country (2021-2032) Figure 30. Europe Emergency Hemostatic Agent Revenue Market Share by Country (2021-2032) Figure 31. Germany Emergency Hemostatic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Emergency Hemostatic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Emergency Hemostatic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Emergency Hemostatic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Netherlands Emergency Hemostatic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Asia Pacific Emergency Hemostatic Agent Market Size by Country in 2025 Figure 37. Asia Pacific Emergency Hemostatic Agent Sales Market Share by Country (2021-2032) Figure 38. Asia Pacific Emergency Hemostatic Agent Revenue Market Share by Country (2021-2032) Figure 39. China Emergency Hemostatic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Japan Emergency Hemostatic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. South Korea Emergency Hemostatic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. India Emergency Hemostatic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Australia Emergency Hemostatic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. China Taiwan Emergency Hemostatic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Southeast Asia Emergency Hemostatic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Southeast Asia Emergency Hemostatic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South America Emergency Hemostatic Agent Market Size by Country in 2025 Figure 48. South America Emergency Hemostatic Agent Sales Market Share by Country (2021-2032) Figure 49. South America Emergency Hemostatic Agent Revenue Market Share by Country (2021-2032) Figure 50. Mexico Emergency Hemostatic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Brazil Emergency Hemostatic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Argentina Emergency Hemostatic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Middle East and Africa Emergency Hemostatic Agent Market Size by Country in 2025 Figure 54. Middle East and Africa Emergency Hemostatic Agent Sales Market Share by Country (2021-2032) Figure 55. Middle East and Africa Emergency Hemostatic Agent Revenue Market Share by Country (2021-2032) Figure 56. Turkey Emergency Hemostatic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Saudi Arabia Emergency Hemostatic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. UAE Emergency Hemostatic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Global Emergency Hemostatic Agent Sales Market Share by Type (2021-2032) Figure 60. Global Emergency Hemostatic Agent Revenue Market Share by Type (2021-2032) Figure 61. Global Emergency Hemostatic Agent Price (US$/Unit) by Type (2021-2032) Figure 62. Global Emergency Hemostatic Agent Sales Market Share by Application (2021-2032) Figure 63. Global Emergency Hemostatic Agent Revenue Market Share by Application (2021-2032) Figure 64. Global Emergency Hemostatic Agent Price (US$/Unit) by Application (2021-2032) Figure 65. Emergency Hemostatic Agent Value Chain Figure 66. Emergency Hemostatic Agent Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Emergency Hemostatic Agent Industry Opportunities and Challenges

Scope & coverage.

Types
  • Gelation Sponge
  • Oxidized Regenerated Cellulose Based Hemostats
  • Others
Applications
  • Clnics
  • Hospitals
  • Surgical Centers
  • Others
Companies covered
  • Advanced Medical Solutions
  • Anika Therapeutics
  • B Braun Melsungen
  • Baxter International
  • BioCer Entwicklungs
  • Biom’Up SAS
  • C. R. Bard
  • CryoLife
  • Equimedical
  • Ethicon
  • Gelita Medical
  • Integra LifeSciences
  • Marine Polymer Technologies
  • The Medicines Company
  • Vascular Solutions
  • Z-Medica
  • Pfizer

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Emergency Hemostatic Agent Market Size (2021-2032)
  4. 2.2.2 Global Emergency Hemostatic Agent Sales (2021-2032)
  5. 2.2.3 Global Emergency Hemostatic Agent Market Average Price (2021-2032)
  6. 2.3 Emergency Hemostatic Agent by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Gelation Sponge
  9. 2.3.3 Oxidized Regenerated Cellulose Based Hemostats
  10. 2.3.4 Others
  11. 2.4 Emergency Hemostatic Agent by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Clnics
  14. 2.4.3 Hospitals
  15. 2.4.4 Surgical Centers
  16. 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Emergency Hemostatic Agent Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Emergency Hemostatic Agent Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Emergency Hemostatic Agent Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Emergency Hemostatic Agent Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Emergency Hemostatic Agent Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Emergency Hemostatic Agent, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Emergency Hemostatic Agent, Product Type & Application
  8. 3.8 Global Manufacturers of Emergency Hemostatic Agent, Established Date
  9. 3.9 Global Emergency Hemostatic Agent Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Advanced Medical Solutions
  2. 4.1.1 Advanced Medical Solutions Company Information
  3. 4.1.2 Advanced Medical Solutions Business Overview
  4. 4.1.3 Advanced Medical Solutions Emergency Hemostatic Agent Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Advanced Medical Solutions Emergency Hemostatic Agent Product Portfolio
  6. 4.1.5 Advanced Medical Solutions Recent Developments
  7. 4.2 Anika Therapeutics
  8. 4.2.1 Anika Therapeutics Company Information
  9. 4.2.2 Anika Therapeutics Business Overview
  10. 4.2.3 Anika Therapeutics Emergency Hemostatic Agent Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Anika Therapeutics Emergency Hemostatic Agent Product Portfolio
  12. 4.2.5 Anika Therapeutics Recent Developments
  13. 4.3 B Braun Melsungen
  14. 4.3.1 B Braun Melsungen Company Information
  15. 4.3.2 B Braun Melsungen Business Overview
  16. 4.3.3 B Braun Melsungen Emergency Hemostatic Agent Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 B Braun Melsungen Emergency Hemostatic Agent Product Portfolio
  18. 4.3.5 B Braun Melsungen Recent Developments
  19. 4.4 Baxter International
  20. 4.4.1 Baxter International Company Information
  21. 4.4.2 Baxter International Business Overview
  22. 4.4.3 Baxter International Emergency Hemostatic Agent Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Baxter International Emergency Hemostatic Agent Product Portfolio
  24. 4.4.5 Baxter International Recent Developments
  25. 4.5 BioCer Entwicklungs
  26. 4.5.1 BioCer Entwicklungs Company Information
  27. 4.5.2 BioCer Entwicklungs Business Overview
  28. 4.5.3 BioCer Entwicklungs Emergency Hemostatic Agent Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 BioCer Entwicklungs Emergency Hemostatic Agent Product Portfolio
  30. 4.5.5 BioCer Entwicklungs Recent Developments
  31. 4.6 Biom’Up SAS
  32. 4.6.1 Biom’Up SAS Company Information
  33. 4.6.2 Biom’Up SAS Business Overview
  34. 4.6.3 Biom’Up SAS Emergency Hemostatic Agent Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Biom’Up SAS Emergency Hemostatic Agent Product Portfolio
  36. 4.6.5 Biom’Up SAS Recent Developments
  37. 4.7 C. R. Bard
  38. 4.7.1 C. R. Bard Company Information
  39. 4.7.2 C. R. Bard Business Overview
  40. 4.7.3 C. R. Bard Emergency Hemostatic Agent Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 C. R. Bard Emergency Hemostatic Agent Product Portfolio
  42. 4.7.5 C. R. Bard Recent Developments
  43. 4.8 CryoLife
  44. 4.8.1 CryoLife Company Information
  45. 4.8.2 CryoLife Business Overview
  46. 4.8.3 CryoLife Emergency Hemostatic Agent Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 CryoLife Emergency Hemostatic Agent Product Portfolio
  48. 4.8.5 CryoLife Recent Developments
  49. 4.9 Equimedical
  50. 4.9.1 Equimedical Company Information
  51. 4.9.2 Equimedical Business Overview
  52. 4.9.3 Equimedical Emergency Hemostatic Agent Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Equimedical Emergency Hemostatic Agent Product Portfolio
  54. 4.9.5 Equimedical Recent Developments
  55. 4.10 Ethicon
  56. 4.10.1 Ethicon Company Information
  57. 4.10.2 Ethicon Business Overview
  58. 4.10.3 Ethicon Emergency Hemostatic Agent Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Ethicon Emergency Hemostatic Agent Product Portfolio
  60. 4.10.5 Ethicon Recent Developments
  61. 4.11 Gelita Medical
  62. 4.11.1 Gelita Medical Company Information
  63. 4.11.2 Gelita Medical Business Overview
  64. 4.11.3 Gelita Medical Emergency Hemostatic Agent Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Gelita Medical Emergency Hemostatic Agent Product Portfolio
  66. 4.11.5 Gelita Medical Recent Developments
  67. 4.12 Integra LifeSciences
  68. 4.12.1 Integra LifeSciences Company Information
  69. 4.12.2 Integra LifeSciences Business Overview
  70. 4.12.3 Integra LifeSciences Emergency Hemostatic Agent Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Integra LifeSciences Emergency Hemostatic Agent Product Portfolio
  72. 4.12.5 Integra LifeSciences Recent Developments
  73. 4.13 Marine Polymer Technologies
  74. 4.13.1 Marine Polymer Technologies Company Information
  75. 4.13.2 Marine Polymer Technologies Business Overview
  76. 4.13.3 Marine Polymer Technologies Emergency Hemostatic Agent Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Marine Polymer Technologies Emergency Hemostatic Agent Product Portfolio
  78. 4.13.5 Marine Polymer Technologies Recent Developments
  79. 4.14 The Medicines Company
  80. 4.14.1 The Medicines Company Company Information
  81. 4.14.2 The Medicines Company Business Overview
  82. 4.14.3 The Medicines Company Emergency Hemostatic Agent Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 The Medicines Company Emergency Hemostatic Agent Product Portfolio
  84. 4.14.5 The Medicines Company Recent Developments
  85. 4.15 Vascular Solutions
  86. 4.15.1 Vascular Solutions Company Information
  87. 4.15.2 Vascular Solutions Business Overview
  88. 4.15.3 Vascular Solutions Emergency Hemostatic Agent Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Vascular Solutions Emergency Hemostatic Agent Product Portfolio
  90. 4.15.5 Vascular Solutions Recent Developments
  91. 4.16 Z-Medica
  92. 4.16.1 Z-Medica Company Information
  93. 4.16.2 Z-Medica Business Overview
  94. 4.16.3 Z-Medica Emergency Hemostatic Agent Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Z-Medica Emergency Hemostatic Agent Product Portfolio
  96. 4.16.5 Z-Medica Recent Developments
  97. 4.17 Pfizer
  98. 4.17.1 Pfizer Company Information
  99. 4.17.2 Pfizer Business Overview
  100. 4.17.3 Pfizer Emergency Hemostatic Agent Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Pfizer Emergency Hemostatic Agent Product Portfolio
  102. 4.17.5 Pfizer Recent Developments
5 Global Emergency Hemostatic Agent Market Scenario by Region
  1. 5.1 Global Emergency Hemostatic Agent Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Emergency Hemostatic Agent Sales by Region: 2021-2032
  3. 5.2.1 Global Emergency Hemostatic Agent Sales by Region: 2021-2026
  4. 5.2.2 Global Emergency Hemostatic Agent Sales by Region: 2027-2032
  5. 5.3 Global Emergency Hemostatic Agent Revenue by Region: 2021-2032
  6. 5.3.1 Global Emergency Hemostatic Agent Revenue by Region: 2021-2026
  7. 5.3.2 Global Emergency Hemostatic Agent Revenue by Region: 2027-2032
  8. 5.4 North America Emergency Hemostatic Agent Market Facts & Figures by Country
  9. 5.4.1 North America Emergency Hemostatic Agent Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Emergency Hemostatic Agent Sales by Country (2021-2032)
  11. 5.4.3 North America Emergency Hemostatic Agent Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Emergency Hemostatic Agent Market Facts & Figures by Country
  15. 5.5.1 Europe Emergency Hemostatic Agent Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Emergency Hemostatic Agent Sales by Country (2021-2032)
  17. 5.5.3 Europe Emergency Hemostatic Agent Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Emergency Hemostatic Agent Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Emergency Hemostatic Agent Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Emergency Hemostatic Agent Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Emergency Hemostatic Agent Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Emergency Hemostatic Agent Market Facts & Figures by Country
  35. 5.7.1 South America Emergency Hemostatic Agent Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Emergency Hemostatic Agent Sales by Country (2021-2032)
  37. 5.7.3 South America Emergency Hemostatic Agent Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Emergency Hemostatic Agent Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Emergency Hemostatic Agent Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Emergency Hemostatic Agent Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Emergency Hemostatic Agent Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Emergency Hemostatic Agent Sales by Type (2021-2032)
  2. 6.1.1 Global Emergency Hemostatic Agent Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Emergency Hemostatic Agent Sales Market Share by Type (2021-2032)
  4. 6.2 Global Emergency Hemostatic Agent Revenue by Type (2021-2032)
  5. 6.2.1 Global Emergency Hemostatic Agent Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Emergency Hemostatic Agent Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Emergency Hemostatic Agent Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Emergency Hemostatic Agent Sales by Application (2021-2032)
  2. 7.1.1 Global Emergency Hemostatic Agent Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Emergency Hemostatic Agent Sales Market Share by Application (2021-2032)
  4. 7.2 Global Emergency Hemostatic Agent Revenue by Application (2021-2032)
  5. 7.2.1 Global Emergency Hemostatic Agent Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Emergency Hemostatic Agent Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Emergency Hemostatic Agent Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Emergency Hemostatic Agent Value Chain Analysis
  2. 8.1.1 Emergency Hemostatic Agent Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Emergency Hemostatic Agent Production Mode & Process
  5. 8.2 Emergency Hemostatic Agent Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Emergency Hemostatic Agent Distributors
  8. 8.2.3 Emergency Hemostatic Agent Customers
9 Global Emergency Hemostatic Agent Analyzing Market Dynamics
  1. 9.1 Emergency Hemostatic Agent Industry Trends
  2. 9.2 Emergency Hemostatic Agent Industry Drivers
  3. 9.3 Emergency Hemostatic Agent Industry Opportunities and Challenges
  4. 9.4 Emergency Hemostatic Agent Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst